<DOC>
	<DOCNO>NCT02966314</DOCNO>
	<brief_summary>The overall hospitalization diagnosis angioedema double year 2000 2009 . Although case represent hereditary angioedema ace-inhibitor induced angioedema , majority episode idiopathic . Idiopathic Angioedema ( IAE ) life- threaten especially affect tissue within respiratory tract . No clear guideline exist management important condition clinician . Current therapy typically include avoidance potential trigger use medication either prophylaxis acute event , antihistamine , corticosteroid , epinephrine . There remain critical need therapeutic option provide effective prophylaxis .</brief_summary>
	<brief_title>Treatment Idiopathic Angioedema With Xolair Add-on Therapy</brief_title>
	<detailed_description>This study randomize , double-blind , placebo-controlled , parallel group trial study effect omalizumab patient 2 episode Idiopathic Angioedema ( IAE ) past 6 month , despite current therapy . This study three period ; screen , treatment , follow-up . Subjects screen period consent screened eligibility criterion . 40 qualified individual enter treatment period . Individuals randomize either monthly subcutaneous administration omalizumab 300mg ( 20 subject ) versus monthly placebo injection ( 20 subject ) addition previously prescribe management plan total 6 month . Individuals enter follow-up period 4 month . Study visit occur monthly treatment period update clinical status administration omalizumab/placebo injection . After , treatment period individual see twice follow-up period . The entire study consist 10 study visit last approx . 10 month .</detailed_description>
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>Adults adolescents 18 year old time screen physician diagnosis idiopathic angioedema . Minimum two episode idiopathic angioedema past 6 month time screen . Management idiopathic angioedema stable controller treatment plan prior 6 month time screening , include patient manage use follow approach : No prophylaxis use demand medication episodes idiopathic angioedema Use prophylactic medication additional demand medication episodes idiopathic angioedema Body Mass Index less equal 50 time screen visit . Complement C4 C1 inhibitor panel within normal reference range . If woman childbearing potential , must agree reliable form birth control include : abstinence , oral contraceptive ( birth control pill ) , Depoprovera , IUD ( intrauterine device ) , doublebarrier contraception ( partner use condom subject use diaphragm ) . Unable give inform write consent , unable adhere outline visit schedule unable tolerate procedure require participation trial . Unable , judgment investigator , comply study procedure and/ direction . Treatment investigational agent within 30 day screen visit . Medical examination laboratory finding may suggest neoplasm , malignancy , history malignancy . Nursing mother , pregnant woman , woman childbearing potential planning pregnancy course study . Any history lifethreatening angioedema affect breathe .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Angioedema</keyword>
	<keyword>Idiopathic Angioedema</keyword>
	<keyword>IAE</keyword>
</DOC>